{"id":4352,"date":"2025-04-08T05:00:49","date_gmt":"2025-04-08T09:00:49","guid":{"rendered":"https:\/\/www.gensight-biologics.com\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/"},"modified":"2026-09-24T00:05:45","modified_gmt":"2026-09-24T04:05:45","slug":"gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024","status":"publish","type":"post","link":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/","title":{"rendered":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024"},"content":{"rendered":"\n<strong>Paris, France, le 8 avril 2025<\/strong>, <strong>07<\/strong><strong>h00 CEST<\/strong> \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 7 avril 2025 son document d\u2019enregistrement universel (URD) 2024 en langue anglaise aupr\u00e8s de l\u2019Autorit\u00e9 des March\u00e9s Financiers (AMF).\n\nLe document d\u2019enregistrement universel inclut notamment :\n<ul>\n \t<li>le rapport financier annuel 2024 ;<\/li>\n \t<li>le rapport de gestion\u00a0;<\/li>\n \t<li>le rapport sur le gouvernement d\u2019entreprise ; et<\/li>\n \t<li>le descriptif du programme de rachat d\u2019actions.<\/li>\n<\/ul>\nCe document d\u2019enregistrement universel peut \u00eatre consult\u00e9 sur le site Internet de la Soci\u00e9t\u00e9 (<a href=\"www.gensight-biologics.com\">www.gensight-biologics.com<\/a>), section Investisseurs, et sur le site de l\u2019AMF (<a href=\"www.amf-france.org\">www.amf-france.org<\/a>).\n","protected":false},"excerpt":{"rendered":"<p>Paris, France, le 8 avril 2025, 07h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 7 avril 2025 son document d\u2019enregistrement universel [&hellip;]<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[54],"tags":[],"featured-area":[],"news-topic":[79],"news-type":[76,80,81],"post-year":[],"class_list":["post-4352","post","type-post","status-publish","format-standard","hentry","category-communiques-de-presse-financiers","news-topic-company-and-personnel","news-type-corporate","news-type-finance","news-type-regulatory"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics\" \/>\n<meta property=\"og:description\" content=\"Paris, France, le 8 avril 2025, 07h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 7 avril 2025 son document d\u2019enregistrement universel [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"GenSight Biologics\" \/>\n<meta property=\"article:published_time\" content=\"2025-04-08T09:00:49+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-09-24T04:05:45+00:00\" \/>\n<meta name=\"author\" content=\"jbenedicto\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"jbenedicto\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/\"},\"author\":{\"name\":\"jbenedicto\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"headline\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024\",\"datePublished\":\"2025-04-08T09:00:49+00:00\",\"dateModified\":\"2026-09-24T04:05:45+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/\"},\"wordCount\":145,\"articleSection\":[\"Communiqu\u00e9 de presse Financier\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/\",\"name\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\"},\"datePublished\":\"2025-04-08T09:00:49+00:00\",\"dateModified\":\"2026-09-24T04:05:45+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/2025\\\/04\\\/08\\\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/home\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#website\",\"url\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/\",\"name\":\"GenSight Biologics\",\"description\":\"Restoring vision while advancing gene therapy\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gensight-biologics.com\\\/fr\\\/#\\\/schema\\\/person\\\/2a44b94f44dbd4ddf0847f47b1768f1f\",\"name\":\"jbenedicto\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g\",\"caption\":\"jbenedicto\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics","og_description":"Paris, France, le 8 avril 2025, 07h00 CEST \u2013 GenSight Biologics (Euronext : SIGHT, ISIN : FR0013183985, \u00e9ligible PEA-PME), soci\u00e9t\u00e9 biopharmaceutique d\u00e9di\u00e9e au d\u00e9veloppement et \u00e0 la commercialisation de th\u00e9rapies g\u00e9niques innovantes pour les maladies neurod\u00e9g\u00e9n\u00e9ratives de la r\u00e9tine et du syst\u00e8me nerveux central, annonce avoir d\u00e9pos\u00e9 le 7 avril 2025 son document d\u2019enregistrement universel [&hellip;]","og_url":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/","og_site_name":"GenSight Biologics","article_published_time":"2025-04-08T09:00:49+00:00","article_modified_time":"2026-09-24T04:05:45+00:00","author":"jbenedicto","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"jbenedicto","Dur\u00e9e de lecture estim\u00e9e":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/#article","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/"},"author":{"name":"jbenedicto","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"headline":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024","datePublished":"2025-04-08T09:00:49+00:00","dateModified":"2026-09-24T04:05:45+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/"},"wordCount":145,"articleSection":["Communiqu\u00e9 de presse Financier"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/","url":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/","name":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024 - GenSight Biologics","isPartOf":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#website"},"datePublished":"2025-04-08T09:00:49+00:00","dateModified":"2026-09-24T04:05:45+00:00","author":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f"},"breadcrumb":{"@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.gensight-biologics.com\/fr\/2025\/04\/08\/gensight-biologics-met-a-disposition-son-document-denregistrement-universel-2024\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gensight-biologics.com\/fr\/home\/"},{"@type":"ListItem","position":2,"name":"GenSight Biologics met \u00e0 disposition son Document d\u2019Enregistrement Universel 2024"}]},{"@type":"WebSite","@id":"https:\/\/www.gensight-biologics.com\/fr\/#website","url":"https:\/\/www.gensight-biologics.com\/fr\/","name":"GenSight Biologics","description":"Restoring vision while advancing gene therapy","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gensight-biologics.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gensight-biologics.com\/fr\/#\/schema\/person\/2a44b94f44dbd4ddf0847f47b1768f1f","name":"jbenedicto","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2c01e1c29f629dac56455efec1ea9cbd23c254b626dfca256f82e444f534c779?s=96&d=mm&r=g","caption":"jbenedicto"}}]}},"_links":{"self":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4352","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/comments?post=4352"}],"version-history":[{"count":2,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4352\/revisions"}],"predecessor-version":[{"id":7031,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/posts\/4352\/revisions\/7031"}],"wp:attachment":[{"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/media?parent=4352"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/categories?post=4352"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/tags?post=4352"},{"taxonomy":"featured-area","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/featured-area?post=4352"},{"taxonomy":"news-topic","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-topic?post=4352"},{"taxonomy":"news-type","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/news-type?post=4352"},{"taxonomy":"post-year","embeddable":true,"href":"https:\/\/www.gensight-biologics.com\/fr\/wp-json\/wp\/v2\/post-year?post=4352"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}